Screener
Ionis Pharmaceuticals IONS Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Ionis Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 5:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000874015-26-000251
FAQ
- What is Ionis Pharmaceuticals's current ratio?
- Ionis Pharmaceuticals (IONS) reported current ratio of 7.9× in Q2 2026.
- How has Ionis Pharmaceuticals's current ratio changed year-over-year?
- Ionis Pharmaceuticals's current ratio increased by 174.8% year-over-year, from 2.9× to 7.9×.
- What is the long-term trend for Ionis Pharmaceuticals's current ratio?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's current ratio has grown at a 0.9% compound annual growth rate (CAGR), from 3.7× to 3.8×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Ionis Pharmaceuticals's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude